Akso Health Group ADR(AHG) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.02 | Insider Own | - | Shs Outstand | 854.0M | Perf Week | -6.95% |
| Market Cap | 0.65B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 22.9M | Perf Month | -40.16% |
| Enterprise Value | 0.65B | PEG | - | EPS next Q | - | Inst Own | 0.03% | Short Float | 0.09% | Perf Quarter | -34.48% |
| Income | -0.02B | P/S | 46.76 | EPS this Y | - | Inst Trans | 20.42% | Short Ratio | 1.24 | Perf Half Y | -68.98% |
| Sales | 0.01B | P/B | 3.6 | EPS next 5Y | - | ROA | -8.35% | Short Interest | 0.02M | Perf YTD | -53.66% |
| Book/sh | 0.21 | P/C | 3818.06 | EPS past 3/5Y | 24.09% 59.38% | ROE | -9.86% | 52W High | -69.6% ($2.50) | Perf Year | -60.38% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | 1.86% 51.13% | ROIC | -10.36% | 52W Low | 4.11% ($0.73) | Perf 3Y | -35.04% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 95.22% | Gross Margin | -8.39% | Volatility(W/M) | 10.67% 10.65% | Perf 5Y | -55.03% |
| Dividend TTM | - | EV/Sales | 46.92 | Sales Y/Y TTM | -6.2% | Oper. Margin | -28.93% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | 2018/8/1 | Quick Ratio | 21.74 | EPS Q/Q | 40.26% | Profit Margin | -135.08% | RSI (14) | 33.38 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 21.77 | Sales Q/Q | 25.62% | SMA20 | -14.78% ($0.89) | Beta | -0.99 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.01 | Earnings | - | SMA50 | -38.4% ($1.23) | Rel Volume | 0.35 | Prev Close | $0.8 |
| Employees | 12 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -51.48% ($1.57) | Avg Volume(3M) | 0.02M | Price | $0.76 |
| IPO | 2017/11/3 | Option/Short | No/Yes | Trades | 93 | Volume | 5,533 | Change | -5.21% |
Company
AHG is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
Akso Health Group is a small healthcare company based in China that previously operated a social e-commerce platform before pivoting its business into the medical sector. More recently, marketing promotional services have become the core driver of its revenue, and the company has identified expanding into U.S. cancer treatment and radiation oncology services as a new growth direction. Because its business structure has been changing rapidly, the stock carries the high volatility typical of companies in transition.
Over the past 1 year, on the lower side
70% below its 1-year high.
AHG has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Opinions on the outlook are split
Positive and negative signals are mixed
Tap to view numbers
Holding long would have lost money
Would have changed by -35.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 0.0%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $649M.
AHG $649M PER -
MCK $105B PER 24.1
COR $62B PER 24.0
CAH $54B PER 32.1
FAQ
What kind of company is AHG?
AHG belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of AHG?
The market cap of AHG is approximately $649M, ranking 2,987 within its sector.
What is the 52-week high and low for AHG?
AHG has recorded a 52-week high of $2.50 and a low of $0.73.
